期刊文献+

RNAi抑制H157细胞Wnt5a表达 被引量:1

Inhibited Expression of Wnt5a in H157 Cell by RNA Interference
下载PDF
导出
摘要 目的构建抑制大鼠Wnt5a基因表达的重组质粒,达到抑制H157细胞Wnt5a表达的目的。方法根据大鼠Wnt5a的基因序列,设计合成含有发夹结构的2条寡核苷酸片段,经退火形成双链后克隆至PAVU6+27载体质粒中,对阳性重组子进行酶切和测序鉴定后转染正常H157细胞,并采用West-ern blot检测Wnt5a蛋白水平表达的变化。结果重组质粒经双酶切后,有目的条带出现,提示Wnt5a干扰片断已克隆至PAVU6+27载体质粒中,DNA测序结果显示插入序列与预先设计完全一致。重组质粒转染H157细胞后经G418筛选,成功获得阳性克隆,Western blot结果显示Wnt5a的蛋白水平表达显著下降。结论成功构建Wnt5a基因RNA干扰表达质粒,明显抑制H157细胞中Wnt5a表达,这为深入研究该基因在非小细胞肺癌发生及侵袭转移中的作用奠定了基础。 Objective To construct PAVU6-Wnt5a/siRNA expression plasmid and inhibit its function in H157 cells. Methods Human siwnt5a was subcloned into PAVU6 + 27, DH10B E. col. i was transformed with the recombinant plasmid, and the ampicillin-resistant clones were identified by double digestion with HindⅢ and BamH Ⅰ and DNA sequencing. H157 cells were transfected with the identified PAVU6-siWnt5a and PAVU6 + 27 by Lipofectamine 2000. Results The DNA fragment obtained by double digestion and DNA sequencing showed that siWnt5a was inserted into the PAVU6 + 27 in correct orientation and reading frame. G418-resistant colonies of H157 cells were obtained. The expression of Wnt5a protein decreased by Western blotting. Conclusion PAVU6-siWnt5a expression plasmid was constructed and inhibited obviously the expression of Wnt5a in H157 cells, which help to further study the carcinogenesis and metastasis role in non-small cell lung cancer of this protein.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2008年第5期325-327,共3页 Cancer Research on Prevention and Treatment
关键词 WNT5A RNAI H157 转染 表达 Wnt5a RNAi H 157 cells Transfect ion Expression
  • 相关文献

参考文献6

  • 1Manabu Kurayoshi, Naohide Oue, Hideki Yamamoto, et al. Ex pression of Wnt-Sa Is Correlated with Aggressiveness of Gastric Cancer by Stimulating Cell Migration and Invasion [J]. Cancer Res,2006,66(21) : 10439-10448.
  • 2Masckauchan TN, Agalliu D, Vorontchikhina M, et al. WntSa Signaling Induces Proliferation and Survival of Endothelial Cells In Vitro and Expression of MMP-1 and Tie-2[J]. Molecular Bio Cell,2006,17(12):5163-5172.
  • 3Good PD, Krikos AJ, Li SX, et al. Expression of small theupeutic RNAs in human cell nuclei[J]. Gene Ther, 1997,4(1 ):45-54.
  • 4Thomas R Keeble, Michael M Halford, Clare Seaman, et al. The Wnt Receptor Ryk Is Required for Wnt5a-Mediated Axon Guidance on the Contralateral Side of the Corpus Callosum[J]. J Neurosci,2006,26(21) :5840-5848.
  • 5Ling-X, Li-F. silencing of antiapoptotic survivin gene by multiple approaches of RNA interference technology [J ]. Biotechniques,2004,36(3) :456-460.
  • 6Craig C, Mello,Darryl Conte JR. Revealing the world of RNA int erference[J]. Nature, 2004,431 (7006) : 338-342.

同被引文献14

  • 1彭秋平,梁后杰,周琪,周进明,傅晓岚,钟大平.己糖激酶-Ⅱ基因在人结肠癌细胞中的表达及其治疗意义[J].中华医学杂志,2007,87(15):1058-1062. 被引量:12
  • 2彭秋平,梁后杰,边志衡,周进明,周琪,钟大平.mTOR信号通路调控HK-Ⅱ表达对结肠癌细胞增殖的影响[J].现代肿瘤医学,2007,15(6):760-762. 被引量:5
  • 3Garber K. Energy deregulation:licensing tumors to grow [J]. Science, 2006,312 (5777) : 1158-1159.
  • 4Hsu PP, Sabatini DM. Cancer Cell Metabolism: Warburg and Beyond[J]. Cell, 2008,134 (6) : 703 707.
  • 5Shaw R J, Cantley LC. Ras, PI (3) K and mTOR signalling controls tumour cell growth [J]. Nature, 2006,441 (7092) : 424- 430.
  • 6Robey RB, Hay Ni. Akt, hexokinase, mTOR : Targeting cellular energy metabolism for cancer therapy [J]. Drug Discovery Today : Disease Mechanisms, 2005,2 ( 2 ): 239- 246.
  • 7Xu RH,Pelicano H, Zhou Y, et al. Inhibition of glycolysis in cancer cells:a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia [J]. Cancer Res,2005,65(2) :613 -621.
  • 8Guertin DA,Sabatini DM. Defining the role of roTOR in cancer [J]. Cancer Cell, 2007,12 (1) : 9-22.
  • 9Garcia JA,Danielpour D. Mammalian target of rapamycin inhibition as a therapeutic strategy in the management of urologic malignancies [J]. Mol Cancer Ther,2008,7(6) : 1347-1354.
  • 10Easton JB, Houghton PJ. mTOR and cancer therapy[J]. Oncogene,2006,25 (48) :6436-6446.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部